Navigation Links
Lifeline Biotechnologies Receives Third Software Patent
Date:9/17/2012

RENO, Nev., Sept. 17, 2012 /PRNewswire/ -- Lifeline Biotechnologies, Inc. (OTC Market: LLBO) announces the award of US Patent #8,231,542 B2 for System For Analyzing Thermal Data Based on Breast Surface Temperature to  Determine Suspect Conditions.

Jim Holmes, Lifeline's CEO said, "This System patent completes our group of three software patents.  We now have our Methods, Device and System patents which provide the Company with protection of its developed technology.  Methods for Collecting and Analyzing Thermal Data Based on Breast Surface Temperature to Determine Suspect Conditions;   Device For Analyzing Thermal Data Based On Breast Surface Temperature For Detection For Use In Determining Cancerous Conditions;  and, System For Analyzing Thermal Data Based On Breast Surface Temperature To Determine Suspect Conditions."

First Warning Systems, Lifeline Biotechnologies' exclusive licensee, is currently updating the patient data collection device and its interpretive software, covered by these patents, to complete the product package in preparation for market entry.  First Warning is conducting a funding round.  Company information is being posted on GUST (an association of angel investors who are accredited and qualified).

About First Warning Systems
First Warning Systems, (FWS) founded in 2008, is based in Reno, NV.  FWS' principal shareholder is Lifeline Biotechnologies, Inc.  Lifeline has licensed (includes a revenue royalty feature) FWS with the worldwide exclusive right for  development, manufacturing, marketing and commercialization of its intellectual property.  The product  is a device and process that detects breast tissue abnormalities.  Many of these tissue abnormalities will develop into breast diseases, some of which will be breast cancers.  The FWS process does not involve compression or radiation and is noninvasive. Three clinical trials with over 650 participants have achieved proof of concept and superior outcomes when compared to other protocols.  FWS is planning a final, limited clinical trial and a 510k device classification to validate the fourth generation of the FWS product. FWS is preparing to apply for a Euro CE Mark to market in the UK, EU and Russian markets. See FWS' video, "Breast Cancer Tumor Progression" at www.firstwarningsystems.com.

About Lifeline Biotechnologies
Lifeline Biotechnologies, Inc. (OTC Market: LLBO) founded in 1994 is based in Reno, NV.  LLBO has invested over $10M in a device and process for early detection of breast tissue abnormalities some of which are cancerous or pre-cancer.  Three "Proof of Concept" clinical trials of over 650 women have been completed and four patents (one hardware, three software) have been awarded. www.lbti.com. Lifeline's efforts continue to have DTC remove the chill and allow trading to resume.

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, the ability to obtain financing, successful development of the Company's product or market acceptance of the product and regulatory and shareholder approval for anticipated actions.

For more information, contact:   Jim Holmes, CEO 775-852-3222     Email: Jholmes@lbti.com           


'/>"/>
SOURCE Lifeline Biotechnologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Lifeline Biotechnologies First Warning Systems
2. Lifeline Biotechnologies, Inc. Receives Patent Award, a Device for Breast Tissue Temperature Analysis for Determining Cancer Conditions
3. Dehaier Medical Receives SFDA Approval for DHR-CPAP-C5
4. TechPrecision Receives Additional Medical Purchase Orders Exceeding $1.5 Million
5. Sinovac Receives Beijing CDC Tender Award to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens
6. NeuroSigma Receives CE Certification
7. Surefire Medicals Infusion System For Embolization Procedures Receives CE Mark Approval
8. Roche receives FDA clearance for herpes simplex virus type 1 and 2 tests
9. NxStage Patient and Advocate Brian Hess Receives Prestigious Honor from American Association of Kidney Patients
10. AcelRx Pharmaceuticals Receives Fourth and Fifth U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
11. China Botanic Receives New Patent on its Comprehensive Method to Enhance the Medicinal Value of Schisandra
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... Germany , May 3, 2016  Axiogenesis has acquired a major investment from Sino-German High-Tech Fund to further ...    Photo - http://photos.prnewswire.com/prnh/20160503/362921 ... ... ... ...
(Date:5/3/2016)... , May 3, 2016   BIOTRONIK , ... today announced Food and Drug Administration (FDA) approval ... that provides heart failure patients with access to ... also have remote monitoring with daily automatic transmission ... heart rate in response to physiological demands. ...
(Date:5/3/2016)... (NYSE: DPLO) announced today that it is celebrating Hepatitis Awareness Month with a campaign to ... personal story and encourage those at risk to get tested and begin the road to ... ... ... (PRNewsFoto/Diplomat Pharmacy, Inc.) ...
Breaking Medicine Technology:
(Date:5/3/2016)... (PRWEB) , ... May 03, 2016 , ... ... presented its 2016 Champion Award to Charles D. Pulido, R.Ph., Co-Founder of ... Wilkins, Pharm.D., M.S., Ph.D., Pharmacy Advisor and Health IT Specialist, Office of the ...
(Date:5/3/2016)... ... ... Calvary Hospital recently hosted a reception to mark a new music program ... Mary, Manning Walsh Home (MMW) in Manhattan. , During the school year, a ... once a week. The music brings a lot of joy to the patients, family ...
(Date:5/3/2016)... ... , ... Sandbox, one of the nation’s leading independent full-service ... created position of executive vice president, chief creative officer.     , In his new ... LA offices. He reports to Nancy Finigan, president of those offices. , “As ...
(Date:5/3/2016)... ... May 03, 2016 , ... University of ... today the launch of its Associates and Bachelor's degrees in Health Studies. Leading ... Rockefeller University, Dr. Torsten N. Wiesel; Chairman and CEO of Fortune 500® company ...
(Date:5/3/2016)... ... May 03, 2016 , ... Each year, about 800,000 people suffer from ... the United States and account for one death every four minutes. Many people ... disabled. HCR ManorCare is launching a video series called “Your Brain,” in conjunction with ...
Breaking Medicine News(10 mins):